SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Dilan Athauda, Thomas Foltynie, The ongoing pursuit of neuroprotective therapies in Parkinson disease, Nature Reviews Neurology, 2014,

    CrossRef

  2. 2
    Kouji Fukuyama, Shunske Tanahashi, Masamitsu Hoshikawa, Rika Shinagawa, Motohiro Okada, Zonisamide regulates basal ganglia transmission via astroglial kynurenine pathway, Neuropharmacology, 2014, 76, 137

    CrossRef

  3. 3
    Anindya Dasgupta, Mrinal Pal, Tapas Ghosh, Uttam Kumar Roy, Sudipto Konar, Supreeti Biswas, Chittaranjan Maity, Differential effects of insulin induced hypoglycaemia upon redox balance in distinct rat brain areas, Oriental Pharmacy and Experimental Medicine, 2013, 13, 4, 279

    CrossRef

  4. 4
    Mustafa Nazıroğlu, Vedat Ali Yürekli, Effects of Antiepileptic Drugs on Antioxidant and Oxidant Molecular Pathways: Focus on Trace Elements, Cellular and Molecular Neurobiology, 2013, 33, 5, 589

    CrossRef

  5. 5
    Kenjiro Ono, Jun-ichi Takasaki, Ryoichi Takahashi, Tokuhei Ikeda, Masahito Yamada, Effects of antiparkinsonian agents on β-amyloid and α-synuclein oligomer formation in vitro, Journal of Neuroscience Research, 2013, 91, 10
  6. 6
    Ikuko Miyazaki, Masato Asanuma, Shinki Murakami, Mika Takeshima, Nao Torigoe, Yoshihisa Kitamura, Ko Miyoshi, Targeting 5-HT1A receptors in astrocytes to protect dopaminergic neurons in parkinsonian models, Neurobiology of Disease, 2013, 59, 244

    CrossRef

  7. 7
    Jan Lewerenz, Sandra J. Hewett, Ying Huang, Maria Lambros, Peter W. Gout, Peter W. Kalivas, Ann Massie, Ilse Smolders, Axel Methner, Mathias Pergande, Sylvia B. Smith, Vadivel Ganapathy, Pamela Maher, The Cystine/Glutamate Antiporter System xc−in Health and Disease: From Molecular Mechanisms to Novel Therapeutic Opportunities, Antioxidants & Redox Signaling, 2013, 18, 5, 522

    CrossRef

  8. 8
    Vedat Ali Yürekli, Semih Gürler, Mustafa Nazıroğlu, Abdülhadi Cihangir Uğuz, Hasan Rifat Koyuncuoğlu, Zonisamide Attenuates MPP(+)-Induced Oxidative Toxicity Through Modulation of Ca2+ Signaling and Caspase-3 Activity in Neuronal PC12 Cells, Cellular and Molecular Neurobiology, 2013, 33, 2, 205

    CrossRef

  9. 9
    Mario Tombini, Giovanni Pellegrino, Giovanni Di Pino, Giovanni Assenza, Zonisamide for seizures in Parkinson's disease with dementia, Seizure, 2013, 22, 4, 324

    CrossRef

  10. 10
    Shinichi Takahashi, Yoshikane Izawa, Norihiro Suzuki, Astroglial pentose phosphate pathway rates in response to high-glucose environments, ASN NEURO, 2012, 4, 2, 71

    CrossRef

  11. 11
    Shinichi Takahashi, Yoshikane Izawa, Norihiro Suzuki, Astrogliopathy as a loss of astroglial protective function against glycoxidative stress under hyperglycemia, Rinsho Shinkeigaku, 2012, 52, 1, 41

    CrossRef

  12. 12
    Masato Asanuma, Ikuko Miyazaki, Yuri Kikkawa, Naotaka Kimoto, Mika Takeshima, Shinki Murakami, Ko Miyoshi, Cyclooxygenase-Independent Neuroprotective Effects of Aspirin Against Dopamine Quinone-Induced Neurotoxicity, Neurochemical Research, 2012, 37, 9, 1944

    CrossRef

  13. 13
    Tomohiro Omura, Masaru Asari, Joe Yamamoto, Naoya Kamiyama, Kumiko Oka, Chisato Hoshina, Chikatoshi Maseda, Toshio Awaya, Yoshikazu Tasaki, Hiroshi Shiono, Keiko Shimizu, Kazuo Matsubara, HRD1 Levels Increased by Zonisamide Prevented Cell Death and Caspase-3 Activation Caused by Endoplasmic Reticulum Stress in SH-SY5Y Cells, Journal of Molecular Neuroscience, 2012, 46, 3, 527

    CrossRef

  14. 14
    Lara E. Jehi, Anna I. Irwin, Hussam Kayyali, Sumeet Vadera, William Bingaman, Imad Najm, Levetiracetam may favorably affect seizure outcome after temporal lobectomy, Epilepsia, 2012, 53, 6
  15. 15
    Josef Finsterer, Sinda Zarrouk Mahjoub, Mitochondrial toxicity of antiepileptic drugs and their tolerability in mitochondrial disorders, Expert Opinion on Drug Metabolism & Toxicology, 2012, 8, 1, 71

    CrossRef

  16. 16
    Marica Carbone, Susan Duty, Marcus Rattray, Riluzole elevates GLT-1 activity and levels in striatal astrocytes, Neurochemistry International, 2012, 60, 1, 31

    CrossRef

  17. 17
    ME Choudhury, K Sugimoto, M Kubo, H Iwaki, T Tsujii, WT Kyaw, N Nishikawa, M Nagai, J Tanaka, M Nomoto, Zonisamide up-regulated the mRNAs encoding astrocytic anti-oxidative and neurotrophic factors, European Journal of Pharmacology, 2012, 689, 1-3, 72

    CrossRef

  18. 18
    Mohammed Emamussalehin Choudhury, Kana Sugimoto, Madoka Kubo, Masahiro Nagai, Masahiro Nomoto, Hisaaki Takahashi, Hajime Yano, Junya Tanaka, A cytokine mixture of GM-CSF and IL-3 that induces a neuroprotective phenotype of microglia leading to amelioration of (6-OHDA)-induced Parkinsonism of rats, Brain and Behavior, 2011, 1, 1
  19. 19
    Ikuko Miyazaki, Masato Asanuma, Yuri Kikkawa, Mika Takeshima, Shinki Murakami, Ko Miyoshi, Norio Sogawa, Taizo Kita, Astrocyte-derived metallothionein protects dopaminergic neurons from dopamine quinone toxicity, Glia, 2011, 59, 3
  20. 20
    Mohammed Emamussalehin Choudhury, Takashi Moritoyo, Madoka Kubo, Win Thiri Kyaw, Hayato Yabe, Noriko Nishikawa, Masahiro Nagai, Seiji Matsuda, Masahiro Nomoto, Zonisamide-induced long-lasting recovery of dopaminergic neurons from MPTP-toxicity, Brain Research, 2011, 1384, 170

    CrossRef

  21. 21
    Sumihiro Kawajiri, Yutaka Machida, Shinji Saiki, Shigeto Sato, Nobutaka Hattori, Zonisamide reduces cell death in SH-SY5Y cells via an anti-apoptotic effect and by upregulating MnSOD, Neuroscience Letters, 2010, 481, 2, 88

    CrossRef